StevenKeiles
New member
Aria,
It is not a stop mutation, it is a frameshift mutation. I am not sure what class it is.
Only mutations that end in X are stop or nonsense mutations. Frameshift mutations do often results in a premature stop codon further done the gene. however these type of stop mutations would be benefit from the PTC124 drug, only the mutations that end in X can use that drug. And that drug is still a little ways from coming to market. They are just completing phase 2 trials, then comes phase 3, then if all goes well FDA approval. So not likely before 2009.
Steve
It is not a stop mutation, it is a frameshift mutation. I am not sure what class it is.
Only mutations that end in X are stop or nonsense mutations. Frameshift mutations do often results in a premature stop codon further done the gene. however these type of stop mutations would be benefit from the PTC124 drug, only the mutations that end in X can use that drug. And that drug is still a little ways from coming to market. They are just completing phase 2 trials, then comes phase 3, then if all goes well FDA approval. So not likely before 2009.
Steve